RKLB - Rocket Lab USA, Inc.
NASDAQ
->
Industrials
->
Aerospace & Defense
Long Beach,
United States
Type: Equity
RKLB price evolution
RKLB
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $61.8 | $48.5 | $52.44 | $73.99 |
| Inventory | $107.86 | $102.4 | $102.23 | $98.45 |
| Total current assets | $476.72 | $506.2 | $560.21 | $635.26 |
| Long term investments | ||||
| Property, plant & equipment | $219.8 | $196 | $182.89 | $146.28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $941.21 | $950.5 | $981.5 | $990.91 |
| Current liabilities | ||||
| Accounts payable | $29.3 | $25 | $25.87 | $22.85 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $223.37 | $303.8 | $305.94 | $197.29 |
| Long term debt | $102.83 | $15.3 | $15.38 | $116.2 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $386.67 | $364.7 | $370.45 | $350.89 |
| Shareholders' equity | ||||
| Retained earnings | -$623.53 | -$573 | -$532.46 | -$486.57 |
| Other shareholder equity | $1.54 | -$2.4 | -$1.76 | $0.57 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.87 | |||
| Short term investments | ||||
| Net receivables | $61.8 | $47.47 | $19.01 | $10.64 |
| Inventory | $107.86 | $92.28 | $47.9 | $26.14 |
| Total current assets | $476.72 | $662.29 | $774.76 | $93.11 |
| Long term investments | ||||
| Property, plant & equipment | $219.8 | $152.37 | $93.76 | $76.73 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $941.21 | $989.12 | $980.85 | $187.87 |
| Current liabilities | ||||
| Accounts payable | $29.3 | $12.08 | $3.49 | $3.37 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $223.37 | $162.94 | $96.31 | $48.42 |
| Long term debt | $102.83 | $115.61 | $97.3 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $386.67 | $315.92 | $282.4 | $79.62 |
| Shareholders' equity | ||||
| Retained earnings | -$623.53 | -$440.95 | -$305.01 | -$187.69 |
| Other shareholder equity | $1.54 | $1.14 | $1.31 | $1.05 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 30 Apr 2022 | 30 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $55.47 | $27.48 | ||
| Cost of revenue | ||||
| Gross Profit | $4.96 | $6.68 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $38.12 | $31.02 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$2.07 | -$6.54 | ||
| Interest expense | -$6.31 | -$2.93 | ||
| Net income | ||||
| Net income | -$37.42 | $3.2 | ||
| Income (for common shares) | ||||
| (in millions $) | 30 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $62.24 | $35.16 | $48.4 | |
| Cost of revenue | ||||
| Gross Profit | -$1.89 | -$11.82 | -$1.08 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $100.16 | $43.13 | $31.82 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$7.52 | $0.47 | $0.35 | |
| Interest expense | -$6.7 | $2.64 | $2.27 | |
| Net income | ||||
| Net income | -$117.32 | -$55.01 | -$30.36 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2022 | 1 May 2022 | 30 Jan 2022 | 29 Oct 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$84.14 | -$71.83 | -$92.13 | -$11.45 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$0.57 | $14.44 | $799.94 | $801.78 |
| Effect of exchange rate | $3.86 | -$0.57 | $2.13 | -$0.6 |
| Change in cash and equivalents | -$145.45 | -$84.3 | $638.15 | $739.85 |
| (in millions $) | 30 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$92.13 | -$37.33 | -$20.6 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $799.94 | $21.48 | -$0.08 | |
| Effect of exchange rate | $2.13 | -$0.15 | $0.31 | |
| Change in cash and equivalents | $638.15 | -$43.76 | -$45.7 | |
News
Fundamentals
| Market cap | $1.78B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 488.92M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.13 |
| Quick ratio | 1.65 |